Each to their own sure, I am aware of this argument and it has some validity.
I would argue that because charting is so widely followed it causes extremes of both under and over valuation which I enjoy taking advantage of.
Therefore I should encourage these ideas.
Charting gives the wrong focus, instead of the business people worry about the shareprice. Mark to market accounting compounds this as people feel that they "lose"money as the shareprice falls.
Refer to the capital raising thread with all the panic and concern for my welfare buying in.
I am often early and concentrated in depressed sectors where I consider a recovery is due. It's not an issue to "lose" money for a couple of years dollar cost averaging into a position.
In other words I think the opposite to everyone else on here, this is a digression but you have to understand.
CDD I guess is industrial services, more civil and environmental engineering office based consultancy.
It's not heavily exposed to mining like it's peers which was once considered a good thing, but if it means overexposure to residential property development than maybe that's not so great.
The sector has seen a strong price recovery, there's dozens of fairly valued or overvalued sectors I have no interest in diworsefying into.
I would be interested in your view of my $70-80m NPAT which is loosely based on historical averages, the reduction of debt, sale of XP solutions and reduced D&A with impairments taken against goodwill.
If that puts us on an attractive valuation then perhaps to buy could make sense or if it doesn't I would like to know and consider exiting my substantial position. I am not holding a strong view on this.
- Forums
- ASX - By Stock
- CDD
- Ann: Cardno appoints Chief Executive Officer
Ann: Cardno appoints Chief Executive Officer, page-8
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CDD (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.5¢ |
Change
0.060(32.4%) |
Mkt cap ! $13.28M |
Open | High | Low | Value | Volume |
19.0¢ | 24.5¢ | 19.0¢ | $52.44K | 271.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 444 | 24.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
30.0¢ | 10 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14017 | 1.060 |
1 | 14492 | 1.035 |
1 | 15000 | 1.030 |
1 | 33300 | 1.025 |
1 | 24875 | 1.005 |
Price($) | Vol. | No. |
---|---|---|
1.080 | 14424 | 2 |
1.095 | 1729 | 1 |
1.125 | 9538 | 1 |
1.140 | 5000 | 1 |
1.150 | 10949 | 1 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CDD (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online